Who are Cadence Health's decision-makers?
Cadence Health's most visible decision-makers are Chris Altchek (Founder and CEO), Dr. David Feldman (Clinical leadership / research), Cadence clinical operations leadership (Care delivery).
- CEO
- Chris Altchek
- CTO/key exec
- Dr. David Feldman
- Founded
- 2020
- Employees
- About 201-500 employees
- HQ
- New York, New York
- Prior exit/Notable
- Former Mic co-founder leading Cadence's chronic-care platform.
- Chris AltchekFounder and CEOFounder since 2020Former Mic co-founder leading Cadence's chronic-care platform.
- Dr. David FeldmanClinical leadership / researchClinical leader reported publiclyPublished research on remote patient care programs.
- Cadence clinical operations leadershipCare deliveryCurrent leadership functionManages clinical programs and health-system execution.
- Cadence technology leadershipTechnology and productCurrent leadership functionBuilds remote monitoring, AI, and integration systems.
Who leads Cadence Health?
Chris Altchek is Founder and CEO; Former Mic co-founder leading Cadence's chronic-care platform. Dr. David Feldman is Clinical leadership / research; Published research on remote patient care programs.
Cadence clinical operations leadership is Care delivery; Manages clinical programs and health-system execution. Cadence technology leadership is Technology and product; Builds remote monitoring, AI, and integration systems. This mix shows where strategy, product, finance, and operational decisions likely concentrate.
Who actually makes buying decisions at Cadence Health?
Budget ownership depends on the purchase. Infrastructure, data, and security vendors should expect technical and finance review; GTM vendors should expect sales, marketing, revenue operations, and finance; healthcare, fintech, legal, and consumer regulated categories add compliance and legal stakeholders.
How is Cadence Health organized as it scales?
Cadence Health's current stage suggests functional leadership around product, engineering, operations, finance, legal/compliance, people, and GTM. Sellers should map the business pain to the executive function most accountable for the metric rather than defaulting only to the CEO.
As of June 2026.Sources:Cadence homepageMobiHealthNews Cadence Series BForge Cadence Solutions IPO profile
Cadence Health — frequently asked questions
